These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Reevaluating cancer risk estimates for short-term exposure scenarios. Halmes NC; Roberts SM; Tolson JK; Portier CJ Toxicol Sci; 2000 Nov; 58(1):32-42. PubMed ID: 11053538 [TBL] [Abstract][Full Text] [Related]
6. Assessing cancer risks from short-term exposures in children. Ginsberg GL Risk Anal; 2003 Feb; 23(1):19-34. PubMed ID: 12635720 [TBL] [Abstract][Full Text] [Related]
7. A risk assessment for acrylonitrile in consumer products. Johnston PK; Rock AR Sci Total Environ; 1990 Dec; 99(3):263-77; discussion 277-9. PubMed ID: 2077659 [TBL] [Abstract][Full Text] [Related]
8. Pesticide residues in food: investigation of disparities in cancer risk estimates. Swirsky Gold L; Stern BR; Slone TH; Brown JP; Manley NB; Ames BN Cancer Lett; 1997 Aug; 117(2):195-207. PubMed ID: 9377547 [TBL] [Abstract][Full Text] [Related]
9. Epidemiological and experimental applications to occupational cancer prevention. Vainio H; Hemminki K J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947 [TBL] [Abstract][Full Text] [Related]
10. Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experiment. Finkelstein DM Biometrics; 1991 Jun; 47(2):669-80. PubMed ID: 1912266 [TBL] [Abstract][Full Text] [Related]
11. Issues in biochemical applications to risk assessment: how do we evaluate individual components of multistage models? Anderson MW Environ Health Perspect; 1987 Dec; 76():175-9. PubMed ID: 3447895 [No Abstract] [Full Text] [Related]
12. Using the biological two-stage model to assess risk from short-term exposures. Chen JJ; Kodell RL; Gaylor DW Risk Anal; 1988 Jun; 8(2):223-30. PubMed ID: 3413310 [TBL] [Abstract][Full Text] [Related]
13. Extrapolation of carcinogenicity between species: qualitative and quantitative factors. Gold LS; Manley NB; Ames BN Risk Anal; 1992 Dec; 12(4):579-88. PubMed ID: 1480802 [TBL] [Abstract][Full Text] [Related]
15. How well can in vitro data predict in vivo effects of chemicals? Rodent carcinogenicity as a case study. Anthony Tony Cox L; Popken DA; Kaplan AM; Plunkett LM; Becker RA Regul Toxicol Pharmacol; 2016 Jun; 77():54-64. PubMed ID: 26879462 [TBL] [Abstract][Full Text] [Related]
17. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies). National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services Natl Toxicol Program Tech Rep Ser; 2002 May; (504):1-357. PubMed ID: 12087420 [TBL] [Abstract][Full Text] [Related]
18. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Gaylor DW Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536 [TBL] [Abstract][Full Text] [Related]
19. Incorporating cell proliferation in quantitative cancer risk assessment: approaches, issues, and uncertainties. Chen C; Farland W Prog Clin Biol Res; 1991; 369():481-99. PubMed ID: 1946541 [No Abstract] [Full Text] [Related]
20. The relationship between carcinogenic potency and maximum tolerated dose is similar for mutagens and nonmutagens. Goodman G; Shlyakhter A; Wilson R Prog Clin Biol Res; 1991; 369():501-16. PubMed ID: 1946542 [No Abstract] [Full Text] [Related] [Next] [New Search]